<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2022-28-6-699-709</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-2249</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Роль rs2297518 гена NOS 2 как генетического биомаркера артериальной гипертонии и фенотипа «артериальная гипертония и головная боль напряжения» (пилотное исследование в Восточной Сибири)</article-title><trans-title-group xml:lang="en"><trans-title>The role of the rs2297518 of NOS 2 gene as a genetic biomarker of arterial hypertension and “arterial hypertension and tension-type headache” phenotype (the pilot study in East Siberia)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8833-1052</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алябьева</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Alyabyeva</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алябьева Полина Викторовна — аспирант центра коллективного пользования «Молекулярные и клеточные технологии»</p><p>ул. Партизана Железняка, д. 1, г. Красноярск, 660022</p></bio><bio xml:lang="en"><p>Polina V. Alyabyeva, Post Graduate Student of Shared Core Facilities “Molecular and Cell Technologies”</p><p>1 Partizana Zheleznyaka str., Krasnoyarsk, 660022 </p></bio><email xlink:type="simple">polina-moscaleva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5965-4362</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Резниченко</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Reznichenko</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Резниченко Полина Анатольевна — студентка 6 курса Лечебного факультета </p><p>г. Красноярск</p></bio><bio xml:lang="en"><p>Polina A. Reznichenko, Student of Medical Faculty</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">polina.reznichenko.98@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2840-837X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шнайдер</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shnayder</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шнайдер Наталья Алексеевна — доктор медицинских наук, профессор, ведущий научный сотрудник центра коллективного пользования «Молекулярные и клеточные технологии» Красноярского ГМУ им. проф. В. Ф. Войно-Ясенецкого; ведущий научный сотрудник Института персонализированной психиатрии и неврологии НМИЦ ПН им. В. М. Бехтерева</p><p>г. Красноярск; Санкт-Петербург</p></bio><bio xml:lang="en"><p>Natalia A. Shnayder, DSci (Med), Professor, Leading Researcher of Shared Core Facilities “Molecular and Cell Technologies” of the V. F. Voino-Yasenetsky Krasnoyarsk State Medical University; Leading Researcher of Institute of Personalized Psychiatry and Neurology of the V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology</p><p>Krasnoyarsk; St Petersburg</p></bio><email xlink:type="simple">naschnaider@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0794-2530</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каскаева</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaskaeva</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каскаева Дарья Сергеевна — кандидат медицинских наук, доцент кафедры поликлинической терапии и семейной медицины с курсом последипломного образования </p><p>г. Красноярск</p></bio><bio xml:lang="en"><p>Darya. S. Kaskaeva, MD, Associate Professor of Department of Outpatient Therapy and Family Medicine</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">dashakas.ru@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8493-0058</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петрова Марина Михайловна — доктор медицинских наук, профессор, заведующий кафедрой кафедры поликлинической терапии и семейной медицины с курсом последипломного образования </p><p>г. Красноярск</p></bio><bio xml:lang="en"><p>Marina M. Petrova, DSci (Med), Professor, Head of Department of Outpatient Therapy and Family Medicine</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">stk99@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Красноярский государственный медицинский университет имени профессора В. Ф. Войно-Ясенецкого» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.F. Voino-Yasenetsky Krasnoyarsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Красноярский государственный медицинский университет имени профессора В. Ф. Войно-Ясенецкого» Министерства здравоохранения Российской Федерации; &#13;
Федеральное государственное бюджетное учреждение «Национальный  медицинский  исследовательский  центр психиатрии и неврологии имени В. М. Бехтерева» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; &#13;
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>14</day><month>09</month><year>2022</year></pub-date><volume>28</volume><issue>6</issue><fpage>699</fpage><lpage>709</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Алябьева П.В., Резниченко П.А., Шнайдер Н.А., Каскаева Д.С., Петрова М.М., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Алябьева П.В., Резниченко П.А., Шнайдер Н.А., Каскаева Д.С., Петрова М.М.</copyright-holder><copyright-holder xml:lang="en">Alyabyeva P.V., Reznichenko P.A., Shnayder N.A., Kaskaeva D.S., Petrova M.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/2249">https://htn.almazovcentre.ru/jour/article/view/2249</self-uri><abstract><p>Оксид азота (NO) играет важную патогенетическую роль в релаксации сосудов и является молекулой кандидатом на роль общего патогенетического звена в развитии артериальной гипертонии (АГ) и головной боли напряжения (ГБН).</p><p>Цель исследования — изучение ассоциации однонуклеотидного варианта (ОНВ) rs2297518 гена NOS 2, кодирующего индуцибельную NO-синтазу, с риском развития АГ и клинического фенотипа «АГ + ГБН» у взрослых трудоспособного возраста, проживающих в крупном промышленном городе Восточной Сибири.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Все участники (N = 91) были разделены на две группы наблюдения: группа 1 (пациенты с АГ) — 60 человек, включая основную подгруппу (пациенты с АГ без головной боли) — 30 человек и сопоставимую подгруппу (пациенты с клиническим фенотипом «АГ + ГБН») — 30 человек; группа 2 (контрольная — здоровые добровольцы) — 31 человек. Определение носительства ОНВ rs2297518 гена NOS 2 (локус 17q11.2) осуществляли с помощью полимеразной цепной реакции в режиме реального времени.</p></sec><sec><title>Результаты</title><p>Результаты. Минорная аллель А rs2297518 гена NOS 2 была статистически значимо ассоциирована с высоким риском развития АГ (отношение шансов (ОШ) = 8,43 [95 % доверительный интервал (ДИ): 2,33-30,46], р = 0,000223) и фенотипа «АГ + ГБН» (ОШ = 5,44 [95 % ДИ: 1,46-20,21], р = 0,006) по сравнению с контрольной группой. При анализе ассоциации гетерозиготного генотипа GA rs2297518 гена NOS 2 также была выявлена его статистически значимая ассоциация с высоким риском развития АГ (ОШ = 8,17 [95 % ДИ: 2,03-32,79], р = 0,001).</p></sec><sec><title>Заключение</title><p>Заключение. Проведенное исследование продемонстрировало, что минорная аллель А ОНВ rs2297518 (26096597 G &gt; A) гена NOS 2, кодирующего индуцибельную NO-синтазу (iNOS), может рассматриваться как клинически значимый генетический биомаркер, в первую очередь, АГ в европейской популяции Восточной Сибири. В тоже время будущие исследования могут уточнить роль этого ОНВ как генетического биомаркера фенотипа «АГ + ГБН».</p></sec></abstract><trans-abstract xml:lang="en"><p>Nitric oxide (NO) plays an important pathogenetic role in vascular relaxation and is a candidate molecule of a common pathogenetic link in the development of arterial hypertension (AH) and tension-type headache (TTH).</p><p>Objective of the study was to study the association of the single nucleotide variant (SNV) rs2297518 of the NOS 2 gene with the risk of developing AH and clinical “AH + TTH” phenotype in adults living in a large industrial city of Eastern Siberia.</p><sec><title>Design and methods</title><p>Design and methods. All participants (N = 91) were divided into two groups: group 1 (patients with AH) — 60 people, including the main subgroup (patients with AH without headache) — 30 people and a comparable subgroup (patients with clinical phenotype “AH + TTH”) — 30 people; group 2 (control — healthy volunteers) — 31 people. Carriage of the SNV rs2297518 gene NOS 2 (locus 17q11.2) was determined using real-time polymerase chain reaction.</p></sec><sec><title>Results</title><p>Results. The minor allele A rs2297518 of the NOS 2 gene was statistically significantly associated with a high risk of developing AH (odds ratio (OR) = 8,43 [95 % confidence interval (CI): 2,33–30,46], p = 0,000223) and phenotype “AH + TTH” (OR = 5,44 [95 % CI: 1,46–20,21], p = 0,006) compared with the control group. The heterozygous genotype GA rs2297518 of the NOS 2 gene also was statistically significantly associated with a high risk of developing AH (OR = 8,17 [95 % CI: 2,03–32,79], p = 0,001).</p></sec><sec><title>Conclusions</title><p>Conclusions. The study demonstrated that the minor allele A of the SNV rs2297518 (26096597 G &gt; A) of the NOS 2 gene, which encodes the inducible NO-synthase (iNOS), can be considered as a clinically significant genetic biomarker, first of all, of AH in the Caucasian population of Eastern Siberia. At the same time, future studies may clarify the role of this SNV as a genetic biomarker of the “AH + TTH” phenotype.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертония</kwd><kwd>коморбидность</kwd><kwd>головная боль напряжения</kwd><kwd>оксид азота</kwd><kwd>генетический биомаркер</kwd><kwd>NOS 2</kwd><kwd>iNOS</kwd><kwd>rs2297518</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>comorbidity</kwd><kwd>tension-type headache</kwd><kwd>nitric oxide</kwd><kwd>genetic biomarker</kwd><kwd>NOS 2</kwd><kwd>iNOS</kwd><kwd>rs2297518</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы выражают благодарность руководителю (доктору медицинских наук Д. В. Дмитренко) и сотрудникам лаборатории медицинской генетики ФГБОУ ВО Красноярский ГМУ им. проф. В. Ф. Войно-Ясенецкого Минздрава России за помощь в проведении генетической диагностики. Исследование выполнено в рамках внутривузовского гранта для поддержки исследований молодых ученых ФГБОУ ВО Красноярский ГМУ им. проф. В. Ф. Войно-Ясенецкого Минздрава России (приказ ректора № 462-осн. от 12.07.2021).</funding-statement><funding-statement xml:lang="en">The authors express their gratitude to the Head (Doctor of Medical Sciences Dmitrenko D. V.) and the Staff of the Laboratory of Medical Genetics of the V. F. Voino-Yasenetsky Krasnoyarsk State Medical University for assistance in conducting genetic diagnostics. The study was carried out within the framework of an intra-university grant to support the research of young scientists of the V. F. Voino-Yasenetsky Krasnoyarsk State Medical University (Rector’s Order No. 462-osn. dated 12.07.2021).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010;23(1):38-45. doi:10.1038/ajh.2009.191</mixed-citation><mixed-citation xml:lang="en">Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010;23(1):38-45. doi:10.1038/ajh.2009.191</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1∙25 million people. Lancet. 2014;383(9932):1899-911. doi:10.1016/S0140-6736(14)60685-1</mixed-citation><mixed-citation xml:lang="en">Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1∙25 million people. Lancet. 2014;383(9932):1899-911. doi:10.1016/S0140-6736(14)60685-1</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Алябьева П. В., Храмченко М. А., Шнайдер Н. А., Каскаева Д. С., Петрова М. М., Насырова Р. Ф. Случай поздней диагностики клинического фенотипа «головная боль напряжения и артериальная гипертония». Лечащий врач. 2022;25(7-8):21-26. doi:10.51793/OS.2022.25.8.003</mixed-citation><mixed-citation xml:lang="en">Alyabieva PV, Kravchenko MA, Shnaider NA, Kaskaeva DS, Petrova MM, Nasyrova RF. A case of late diagnosis of the clinical phenotype “tension-type headache and arterial hypertension”. Lechaschi Vrach J. 2022;25(7-8):21-26. In Russian. doi:10.51793/OS.2022.25.8.003</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202</mixed-citation><mixed-citation xml:lang="en">Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Петрова М. М., Москалева П. В., Шнайдер Н. А., Насырова Р. Ф. Коморбидность артериальной гипертонии и головной боли напряжения. Кардиология. 2020;60(10):132-140. doi:10.18087/cardio.2020.10.n1363</mixed-citation><mixed-citation xml:lang="en">Petrova MM, Moskaleva PV, Shnayder NA, Nasyrova RF. Comorbidity of arterial hypertension and tension-type headache. Kardiologiia = Cardiology. 2020;60(10):132-140. In Russian. doi:10.18087/cardio.2020.10. n1363</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Морозова Н. И., Мулерова Т. А., Цыганкова Д. П., Индукаева Е. В., Баздырев Е. Д., Нахратова О. В. и др. Факторы, предрасполагающие к прогрессированию атеросклероза каротидных артерий у пациентов с артериальной гипертензией. Сибирское медицинское обозрение. 2022;(1):37-44. doi:10.20333/25000136-2022-1-37-44</mixed-citation><mixed-citation xml:lang="en">Morozova NI, Mulerova ТА, Tsygankova DP, Indukaeva EV, Bazdyrev ED, Nahratova OV et al. Factors predisposing to carotid atherosclerosis progression in patients with arterial hypertension. Sib Med Rev. 2022;(1):37-44. In Russian. doi:10.20333/25000136-2022-1-37-44</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhai Z, Wang Z, Wang L, Chen S, Ren H, Wang D. Relationship between inducible NOS single-nucleotide polymorphisms and hypertension in Han Chinese. Herz. 2017;43(5): 461- 465. doi:10.1007/s00059-017-4591-0</mixed-citation><mixed-citation xml:lang="en">Zhai Z, Wang Z, Wang L, Chen S, Ren H, Wang D. Relationship between inducible NOS single-nucleotide polymorphisms and hypertension in Han Chinese. Herz. 2017;43(5): 461- 465. doi:10.1007/s00059-017-4591-0</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Oliveira-Paula GH, Lacchini R, Coeli-Lacchini FB, Junior HM, Tanus-Santos JE. Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy. Gene. 2013;515(2):391-395. doi:10.1016/j.gene.2012.12.059</mixed-citation><mixed-citation xml:lang="en">Oliveira-Paula GH, Lacchini R, Coeli-Lacchini FB, Junior HM, Tanus-Santos JE. Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy. Gene. 2013;515(2):391-395. doi:10.1016/j.gene.2012.12.059</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nikkari ST, Määttä KM, Kunnas TA. Functional inducible nitric oxide synthase gene variants associate with hypertension. Medicine (Baltimore). 2015;94(46):e1958. doi:10.1097/MD.0000000000001958</mixed-citation><mixed-citation xml:lang="en">Nikkari ST, Määttä KM, Kunnas TA. Functional inducible nitric oxide synthase gene variants associate with hypertension. Medicine (Baltimore). 2015;94(46):e1958. doi:10.1097/MD.0000000000001958</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Shnayder N, Petrova M, Moskaleva P, Shesternya P, Pozhilenkova E, Nasyrova R. The role of single-nucleotide variants of NOS 1, NOS 2, and NOS 3 genes in the comorbidity of arterial hypertension and tension-type headache. Molecules. 2021;26(1556):1-15. doi:10.3390/brainsci11060753</mixed-citation><mixed-citation xml:lang="en">Shnayder N, Petrova M, Moskaleva P, Shesternya P, Pozhilenkova E, Nasyrova R. The role of single-nucleotide variants of NOS 1, NOS 2, and NOS 3 genes in the comorbidity of arterial hypertension and tension-type headache. Molecules. 2021;26(1556):1-15. doi:10.3390/brainsci11060753</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Попова А. А., Березикова Е. Н., Маянская С. Д., Яковлева Н. Ф. Эндотелиальная дисфункция и механизмы ее формирования. Сибирское медицинское обозрение. 2010;4(64):7-11</mixed-citation><mixed-citation xml:lang="en">Popova AA, Berezikova EN, Mayanskaya SD, Yakovleva NF. Mechanism of endothelial dysfunction development. Sib Med Rev. 2010;4(64):7-11. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Голиков ПП. Оксид азота в клинике неотложных заболеваний. Глава 4. Сердечно-сосудистая система и генерация оксида азота. Москва: ИД Медпрактика-М, 2004. C. 61-76</mixed-citation><mixed-citation xml:lang="en">Golikov PP. Nitric oxide in emergency deseases. Chapter 4. Cardiovascular system and generation of nitric oxide. Moscow: PH Medpractika-M; 2004. P. 61-76.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: Recent advances. Pharmacol Rev. 2009;61(1):62-97. doi:10.1124/pr.108.000547</mixed-citation><mixed-citation xml:lang="en">Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: Recent advances. Pharmacol Rev. 2009;61(1):62-97. doi:10.1124/pr.108.000547</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nasyrova R, Moskaleva P, Vaiman E, Shnayder N, Blatt N, Rizvanov A. Genetics factors of nitric oxid’s system in psychoneurological disorders. Int J Mol Sci. 2020;21(5):1604. doi:10.3390/ijms21051604</mixed-citation><mixed-citation xml:lang="en">Nasyrova R, Moskaleva P, Vaiman E, Shnayder N, Blatt N, Rizvanov A. Genetics factors of nitric oxid’s system in psychoneurological disorders. Int J Mol Sci. 2020;21(5):1604. doi:10.3390/ijms21051604</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Herken H, Uz E, Ozyurt H, Akyol O. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res. 2001;52(3):289-290. doi:10.1016/s0920-9964(00)00169-9</mixed-citation><mixed-citation xml:lang="en">Herken H, Uz E, Ozyurt H, Akyol O. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res. 2001;52(3):289-290. doi:10.1016/s0920-9964(00)00169-9</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hancock DB, Martin ER, Vance JM, Scott WK. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease. Neurogenetics. 2008;9(4):249-262. doi:10.1007/s10048-008-0137-1</mixed-citation><mixed-citation xml:lang="en">Hancock DB, Martin ER, Vance JM, Scott WK. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease. Neurogenetics. 2008;9(4):249-262. doi:10.1007/s10048-008-0137-1</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Levinsson A, Olin AC, Björck L, Rosengren A, Nyberg F. Nitric oxide synthase (NOS) single nucleotide polymorphisms are associated with coronary heart disease and hypertension in the INTERGENE study. Nitric Oxide. 2014;39:1-7. doi:10.1016/j.niox.2014.03.164</mixed-citation><mixed-citation xml:lang="en">Levinsson A, Olin AC, Björck L, Rosengren A, Nyberg F. Nitric oxide synthase (NOS) single nucleotide polymorphisms are associated with coronary heart disease and hypertension in the INTERGENE study. Nitric Oxide. 2014;39:1-7. doi:10.1016/j.niox.2014.03.164</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S et al. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003;41(6):938-945. doi:10.1016/s0735-1097(02)03011-5</mixed-citation><mixed-citation xml:lang="en">Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S et al. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003;41(6):938-945. doi:10.1016/s0735-1097(02)03011-5</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Men C, Tang K, Lin G, Li J, Zhan Y. ENOS-G894T polymorphism is a risk factor for essential hypertension in China. Indian J Biochem Biophys. 2011;48(3):154-157.</mixed-citation><mixed-citation xml:lang="en">Men C, Tang K, Lin G, Li J, Zhan Y. ENOS-G894T polymorphism is a risk factor for essential hypertension in China. Indian J Biochem Biophys. 2011;48(3):154-157.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gamil S, Erdmann J, Abdalrahman IB, Mohamed AO. Association of NOS 3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study. BMC Med Genet. 2017;18(1):128. doi:10.1186/s12881-017-0491-7</mixed-citation><mixed-citation xml:lang="en">Gamil S, Erdmann J, Abdalrahman IB, Mohamed AO. Association of NOS 3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study. BMC Med Genet. 2017;18(1):128. doi:10.1186/s12881-017-0491-7</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nassereddine S, Idrissi HH, Habbal R, Abouelfath R, Korch F, Haraka M et al. The polymorphism G894T of endothelial nitric oxide synthase (eNOS) gene is associated with susceptibility to essential hypertension (EH) in Morocco. BMC Med Genet. 2018;19(1):127. doi:10.1186/s12881-018-0638-1</mixed-citation><mixed-citation xml:lang="en">Nassereddine S, Idrissi HH, Habbal R, Abouelfath R, Korch F, Haraka M et al. The polymorphism G894T of endothelial nitric oxide synthase (eNOS) gene is associated with susceptibility to essential hypertension (EH) in Morocco. BMC Med Genet. 2018;19(1):127. doi:10.1186/s12881-018-0638-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mattila JT, Thomas AC. Nitric oxide synthase: noncanonical expression patterns. Front Immunol. 2014;5:478. doi:10.3389/fimmu.2014.00478</mixed-citation><mixed-citation xml:lang="en">Mattila JT, Thomas AC. Nitric oxide synthase: noncanonical expression patterns. Front Immunol. 2014;5:478. doi:10.3389/fimmu.2014.00478</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djurinovic D, Odeberg J et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397- 406. doi:10.1074/mcp.M113.035600</mixed-citation><mixed-citation xml:lang="en">Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djurinovic D, Odeberg J et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397- 406. doi:10.1074/mcp.M113.035600</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Olesen J. Nitric oxide-related drug targets in headache. Indeed, selective n-NOS and i-NOS inhibitors are already in early clinical development. Neurotherapeutics. 2010;7(2):183-190. doi:10.1016/j.nurt.2010.03.006</mixed-citation><mixed-citation xml:lang="en">Olesen J. Nitric oxide-related drug targets in headache. Indeed, selective n-NOS and i-NOS inhibitors are already in early clinical development. Neurotherapeutics. 2010;7(2):183-190. doi:10.1016/j.nurt.2010.03.006</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">NCBI. Available online: https://www.ncbi.nlm.nih.gov/snp/ (accessed on 8 September 2022).</mixed-citation><mixed-citation xml:lang="en">NCBI. Available online: https://www.ncbi.nlm.nih.gov/snp/ (accessed on 8 September 2022).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Geography of Genetic Variants Browser. Available online: http://www.popgen.uchicago.edu/ggv (accessed on 8 September 2022)</mixed-citation><mixed-citation xml:lang="en">Geography of Genetic Variants Browser. Available online: http://www.popgen.uchicago.edu/ggv (accessed on 8 September 2022)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Wang X, Laird N, Zuckerman B, Stubblefield P, Xu X. Polymorphism in maternal LRP8 gene is associated with fetal growth. Am J Hum Genet. 2006;78(5):770-777. doi:10.1086/503712</mixed-citation><mixed-citation xml:lang="en">Wang L, Wang X, Laird N, Zuckerman B, Stubblefield P, Xu X. Polymorphism in maternal LRP8 gene is associated with fetal growth. Am J Hum Genet. 2006;78(5):770-777. doi:10.1086/503712</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yi X, Zhu L, Sui G, Li J, Luo H, Yu M et al. Inflammation and endothelial function relevant genetic polymorphisms and carotid plaque in Chinese population. J Atheroscler Thromb. 2020;27(9):978-994. doi:10.5551/jat.53074</mixed-citation><mixed-citation xml:lang="en">Yi X, Zhu L, Sui G, Li J, Luo H, Yu M et al. Inflammation and endothelial function relevant genetic polymorphisms and carotid plaque in Chinese population. J Atheroscler Thromb. 2020;27(9):978-994. doi:10.5551/jat.53074</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">O’Neill S, Brault J, Stasia MJ, Knaus UG. Genetic disorders coupled to ROS deficiency. Redox Biol. 2015;6:135-156. doi:10.1016/j.redox.2015.07.009</mixed-citation><mixed-citation xml:lang="en">O’Neill S, Brault J, Stasia MJ, Knaus UG. Genetic disorders coupled to ROS deficiency. Redox Biol. 2015;6:135-156. doi:10.1016/j.redox.2015.07.009</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mansur TOS, Gonçalves FM, Martins-Oliveira A, Speciali JG, Dach F, Lacchini R et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012;364(1-2):303-308. doi:10.1007/s11010-012-1231-0</mixed-citation><mixed-citation xml:lang="en">Mansur TOS, Gonçalves FM, Martins-Oliveira A, Speciali JG, Dach F, Lacchini R et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012;364(1-2):303-308. doi:10.1007/s11010-012-1231-0</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Gonçalves FM, Luizon MR, Speciali JG, Martins-Oliveira A, Dach F, Tanus-Santos JE. Interaction among nitric oxide (NO)related genes in migraine susceptibility. Mol Cell Biochem. 2012;370(1-2):183-189. doi:10.1007/s11010-012-1409-5</mixed-citation><mixed-citation xml:lang="en">Gonçalves FM, Luizon MR, Speciali JG, Martins-OliveiraA, Dach F, Tanus-Santos JE. Interaction among nitric oxide (NO)related genes in migraine susceptibility. Mol Cell Biochem. 2012;370(1-2):183-189. doi:10.1007/s11010-012-1409-5</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ran C, Michalska JM, Fourier C, Sjostrand C, Waldenlind E, Steinberg A et al. Analysis of NOS Gene polymorphisms in relation to cluster headache and predisposing factors in Sweden. Brain Sci. 2020;11(1):34. doi:10.3390/brainsci11010034</mixed-citation><mixed-citation xml:lang="en">Ran C, Michalska JM, Fourier C, Sjostrand C, Waldenlind E, Steinberg A et al. Analysis of NOS Gene polymorphisms in relation to cluster headache and predisposing factors in Sweden. Brain Sci. 2020;11(1):34. doi:10.3390/brainsci11010034</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wigner P, Czarny P, Synowiec E, Bijak M, Bialek K, Talarowska M et al. Variation of genes involved in oxidative and nitrosative stresses in depression. Eur Psychiatry. 2018;48:38-48. doi:10.1016/j.eurpsy.2017.10.012</mixed-citation><mixed-citation xml:lang="en">Wigner P, Czarny P, Synowiec E, Bijak M, Bialek K, Talarowska M et al. Variation of genes involved in oxidative and nitrosative stresses in depression. Eur Psychiatry. 2018;48:38-48. doi:10.1016/j.eurpsy.2017.10.012</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Huang X, He F. Mechanism and role of nitric oxide signaling in periodontitis. Exp Ther Med. 2019;18(5):3929-3935. doi:10.3892/etm.2019.8044</mixed-citation><mixed-citation xml:lang="en">Wang Y, Huang X, He F. Mechanism and role of nitric oxide signaling in periodontitis. Exp Ther Med. 2019;18(5):3929-3935. doi:10.3892/etm.2019.8044</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto Y, Kiyohara C, Suetsugu-Ogata S, Hamada N, Nakanishi Y. Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: a case-control study in Japan. Oncol Lett. 2017;13(5):3873-3881. doi:10.3892/ol.2017.5867</mixed-citation><mixed-citation xml:lang="en">Yamamoto Y, Kiyohara C, Suetsugu-Ogata S, Hamada N, Nakanishi Y. Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: a case-control study in Japan. Oncol Lett. 2017;13(5):3873-3881. doi:10.3892/ol.2017. 5867</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Feng K, Yue M, Lu X, Zheng Q, Zhang H et al. A non-synonymous SNP in the NOS 2 associated with septic shock in patients with sepsis in Chinese populations. Hum Genet. 2013;132(3):337-346. doi:10.1007/s00439-012-1253-4</mixed-citation><mixed-citation xml:lang="en">Wang Z, Feng K, Yue M, Lu X, Zheng Q, Zhang H et al. A non-synonymous SNP in the NOS 2 associated with septic shock in patients with sepsis in Chinese populations. Hum Genet. 2013;132(3):337-346. doi:10.1007/s00439-012-1253-4</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Paul KC, Sinsheimer JS, Rhodes SL, Cockburn M, Bronstein J, Ritz B. Organophosphate pesticide exposures, nitric oxide synthase gene variants, and gene-pesticide interactions in a case-control study of Parkinson’s disease, California (USA). Environ Health Perspect. 2016;124(5):570-577. doi:10.1289/ehp.1408976</mixed-citation><mixed-citation xml:lang="en">Paul KC, Sinsheimer JS, Rhodes SL, Cockburn M, Bronstein J, Ritz B. Organophosphate pesticide exposures, nitric oxide synthase gene variants, and gene-pesticide interactions in a case-control study of Parkinson’s disease, California (USA). Environ Health Perspect. 2016;124(5):570-577. doi:10.1289/ehp.1408976</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Montesanto A, Crocco P, Tallaro F, Pisani F, Mazzei B, Mari V et al. Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans. Biogerontology. 2013;14(2):177-186. doi:10.1007/s10522-0139421-z</mixed-citation><mixed-citation xml:lang="en">Montesanto A, Crocco P, Tallaro F, Pisani F, Mazzei B, Mari V et al. Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans. Biogerontology. 2013;14(2):177-186. doi:10.1007/s10522-0139421-z</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Moskaleva PV, Shnayder NA, Petrova MM, Kaskaeva DS, Gavrilyuk OA, Radostev SV et al. The role of single nucleotide variants of NOS 1, NOS 2 and NOS 3 genes in the development of the phenotype of migraine and arterial hypertension. Brain Sci. 2021;11(6):753. doi:10.3390/brainsci11060753</mixed-citation><mixed-citation xml:lang="en">Moskaleva PV, Shnayder NA, Petrova MM, Kaskaeva DS, Gavrilyuk OA, Radostev SV et al. The role of single nucleotide variants of NOS 1, NOS 2 and NOS 3 genes in the development of the phenotype of migraine and arterial hypertension. Brain Sci. 2021;11(6):753. doi:10.3390/brainsci11060753</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Москалева П. В., Храмченко М. А., Карпенкова А. Д., Петрова М. М., Шнайдер Н. А. Современные представления о патогенезе головной боли напряжения и о механизмах развития фенотипа «головная боль напряжения и артериальная гипертония». Российский неврологический журнал. 2022;27(2):22- 33. doi:10.30629/2658-7947-2022-27-2-22-33</mixed-citation><mixed-citation xml:lang="en">Moskaleva PV, Khramchenko MA, Karpenkova AD, Petrova MM, Shnayder NA. Modern concepts about pathogenesis of the tension-type headache and mechanisms of development of the tension-type headache and arterial hypertension phenotype. Russ Neuro J. 2022;27(2):22-33. In Russian. doi:10.30629/2658-7947-2022-27-2-22-33</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж. Д., Конради А. О., Недогода С. В., Шляхто Е. В., Арутюнов Г. П., Баранова Е. И. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;3786</mixed-citation><mixed-citation xml:lang="en">Kobalava ZD, Konradi AO, Nedogoda SV, Shlyakhto EV, Arutyunov GP, Baranova EI et al. Arterial hypertension in adults. Clinical guidelines 2020. Russ J Cardiol. 2020;3786. In Russian.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
